<div>Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.</div>

Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.

Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

<div>Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>

</div>

News

Science

Medicine

Health & Fitness

Business News

Life Sciences

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>



Share Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

Sign up to save your podcasts

Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

More shows like HCPLive Podcasts

Evidence-Based GI: An ACG Publication and Podcast